11.14.05: Biotechnology Report
A roundtable forum and top management from 15 firms examine the Biotechnology sector in this 67 page report from The Wall Street Transcript.
  1. Roundtable Forum: Matt Duffy, Black Diamond Research; Edward Nash, Legg Mason Wood Walker; Derek Taller, Cathay Financial

  2. Off the Record: Off the Record asks company leadership which management teams in their sector they most respect for their ability to execute and generate shareholder value.

  3. CEO Interviews (average 2,500 words): Top management from 15 sector firms examine the outlook for their firm and sector. Firms interviewed include: Akers Biosciences, ARIUS Research, Avigen, Dermisonics, DNAPrint genomics, Ecopia Biosciences, Immunomedics, International Bio Recovery, Matritech, MicroMed Cardiovascular, Orthologic Corp., Samaritan Pharmaceuticals, Stressgen Biotechnologies and Transition Therapeutics.

    Topics covered: Valuation expectations  - Big Pharma M&A  - Franchises  - Joint ventures and partnerships  - Licensing deals  - Regulatory risk  - FTC activity  - FDA regulations  - Drug safety profiles  - Therapeutic areas  - Oncology space  - IPO pipeline 

    Companies covered: Cubist (CBST), Pfizer (PFE), Nektar (NKTR), Bristol-Myers (BMY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Genzyme (GENZ), Celgene (CELG), Merck (MRK), Genentech (DNA), Biogen Idec (BIIB), United Therapeutics (UTHR), Onyx Pharmaceuticals (ONXX), Medicines Company (MDCO), Vertex Pharmaceuticals (VRTX), ImClone Systems (IMCL) and Gilead Sciences (GILD).
    ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us

    For immediate access online - click here to gain a password.  

    Report details:  
    Your Name:  
    Company: 
    Address: 
    City: 
    State/Province:
    ZIP/Postal Code:
       
    Country:
    Phone:
    E-Mail:

    BILLING INFORMATION
    Credit Card
    Expiration Month/Year:
    Credit Card Number: 

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

 



Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.


Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher

HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE